Irradiation plus ADT with GnRH antagonist vs. GnRH agonist shows similar efficacy in high risk locally advanced PC

Study shows association between tumour KIM-1 gene (HAVCR1) expression and immune infiltrates in RCC

Guiding metastasis-directed therapy with different PET/CT radiotracers affects distant disease control in HSPC patients

Outcomes of radium-223 and SABR versus SABR for oligometastatic prostate cancers

Bladder cancer updates from the second half of 2024

EMUC 2024: Optimising strategies in mHSPC and mCRPC

Fracture risk increases following cancer therapies for advanced prostate cancer

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study

Laser oncosurgery - A new perspective in treating cancer

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

ESMO 2024: Highlights and analysis

Watchful waiting vs intravesical BCG in high grade pT1 bladder cancer